Capstone Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-68,800
Closed -$12.2M 1392
2020
Q1
$12.2M Buy
68,800
+3,700
+6% +$697K 0.2% 103
2019
Q4
$12.4M Buy
65,100
+17,500
+37% +$3.16M 0.07% 299
2019
Q3
$8.01M Buy
47,600
+9,600
+25% +$1.56M 0.06% 325
2019
Q2
$6.36M Buy
38,000
+13,700
+56% +$1.9M 0.05% 400
2019
Q1
$3.56M Buy
24,300
+13,000
+115% +$1.88M 0.03% 443
2018
Q4
$1.51M Buy
11,300
+5,200
+85% +$852K 0.02% 512
2018
Q3
$1.16M Buy
6,100
+5,800
+1,933% +$1.07M 0.01% 554
2018
Q2
$50K Buy
+300
New +$48.2K ﹤0.01% 650
2017
Q2
Sell
-10,800
Closed -$2.58M 1028
2017
Q1
$2.58M Hold
10,800
0.06% 234
2016
Q4
$2.27M Buy
+10,800
New +$2.24M 0.07% 255
2016
Q3
Sell
-55,000
Closed -$12.7M 970
2016
Q2
$12.7M Buy
+55,000
New +$12.7M 0.24% 73
2016
Q1
Sell
-50,000
Closed -$15.6M 806
2015
Q4
$15.6M Buy
+50,000
New +$14.9M 0.42% 62
2015
Q3
Sell
-45,000
Closed -$13.7M 451
2015
Q2
$13.7M Sell
45,000
-5,000
-10% -$1.49M 0.19% 112
2015
Q1
$14.9M Sell
50,000
-187,000
-79% -$53.3M 0.24% 83
2014
Q4
$61M Buy
237,000
+216,500
+1,056% +$54.1M 0.87% 19
2014
Q3
$4.95M Buy
+20,500
New +$4.59M 0.06% 221
2014
Q2
Sell
-106,100
Closed -$21.8M 483
2014
Q1
$21.8M Buy
106,100
+63,800
+151% +$12.6M 0.28% 63
2013
Q4
$7.11M Sell
42,300
-21,400
-34% -$3.35M 0.08% 144
2013
Q3
$9.17M Buy
63,700
+34,600
+119% +$4.61M 0.09% 120
2013
Q2
$3.67M Buy
+29,100
New +$3.29M 0.04% 176

Other funds holding AGN

Capstone Investment Advisors's AGN Position: Q2 2020 in Review

Capstone Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91,010 shares — an estimated $16.1M sold.

Capstone Investment Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $106M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capstone Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 91,010 Allergan plc shares in Q2 2020, an estimated $16.1M.
  • Capstone Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Capstone Investment Advisors's Allergan plc position peaked at $106M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capstone Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.